Libros bestsellers hasta 50% dcto  Ver más

menú

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy (en Inglés)
Formato
Libro Físico
Editorial
Idioma
Inglés
N° páginas
109
Encuadernación
Tapa Blanda
Dimensiones
23.4 x 19.6 x 0.5 cm
Peso
0.23 kg.
ISBN13
9783030683337
N° edición
1

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy (en Inglés)

José Cleberson Santos Soares (Autor) · Springer · Tapa Blanda

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy (en Inglés) - Cavalcanti, Iago Dillion Lima ; Soares, José Cleberson Santos

Libro Nuevo

$ 125.24

$ 208.73

Ahorras: $ 83.49

40% descuento
  • Estado: Nuevo
Origen: Reino Unido (Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el Martes 11 de Junio y el Viernes 21 de Junio.
Lo recibirás en cualquier lugar de Estados Unidos entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy (en Inglés)"

This work covers the pathophysiology of cancer, exploring the difficulty of optimal treatment due to the complexity and diversity of cancer types. The search for distinctive molecular biology characteristics of tumor cells is especially relevant in the identification of overexpressed receptors and proteins that can be used as a target for cancer treatment.We highlight the main therapeutic modalities, particularly conventional systemic chemotherapy, addressing its mechanisms of action, therapeutic classes and even the toxic effects. We also describe the main tumor markers, their importance in the diagnosis and treatment of cancer, and the specificity of tumor cells. The first chapters serve as an introduction to the central topic of this book, targeted therapy. Key aspects of target therapy, such as classes of drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors, cancer vaccines and tyrosine kinase inhibitors are presented, and, for each one, the benefits, as well as the adverse effects are reported. Chapter 6 compares conventional systemic chemotherapy and targeted therapy, identifies the risks and benefits and also the eligibility criteria for patient care. The possibility of targeted therapy replacing conventional chemotherapy is discussed while reviewing studies that demonstrate the benefits of combining both types of treatment. Finally, the introduction of pharmaceutical nanotechnology to improve antineoplastic agents is addressed in the last chapter and sets the direction for future research in cancer treatment. This is a valuable resource for many health professionals including physicians, pharmacists, nurses, researchers and students interested in the field of oncology.

Opiniones del libro

Ver más opiniones de clientes
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Preguntas frecuentes sobre el libro

Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes